Isoxazole compound for the treatment of cancer

Details for Australian Patent Application No. 2008309562 (hide)

Owner Novartis AG

Inventors Quadt, Cornelia; Garcia-Echeverria, Carlos; Schoepfer, Joseph; Radimerski, Thomas; Chene, Patrick; Jensen, Michael Rugaard

Agent Davies Collison Cave

Pub. Number AU-B-2008309562

PCT Pub. Number WO2009/047323

Priority 07118421.2 12.10.07 EP

Filing date 10 October 2008

Wipo publication date 16 April 2009

Acceptance publication date 19 January 2012

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/5377 (2006.01)

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/047323 Priority application(s): WO2009/047323

19 January 2012 Application Accepted

  Published as AU-B-2008309562

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008309571-Process for foil ripening of cheese

2008309553-Method of producing nucleosides